Uncoupling Protein 2 is a protein that ucp2 is a mitochondrial anion carrier protein that uncouples oxidative phosphorylation:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
UCP2 is a member of the mitochondrial carrier protein family. It contains:
- Six transmembrane alpha-helices: Form the mitochondrial inner membrane transport channel
- Three repeat motifs: Characteristic of mitochondrial carriers
- Nucleotide-binding pocket: Bind nucleotides (ATP, GDP)
- Matrix and intermembrane space domains: Regulatory regions
UCP2 forms homodimers in the inner mitochondrial membrane and functions as a regulated proton transporter.
UCP2 is a mitochondrial anion carrier protein that uncouples oxidative phosphorylation:
- Proton leak: Dissipates the proton gradient across the inner mitochondrial membrane
- Thermogenesis: Generates heat without ATP production
- Metabolic regulation: Modulates cellular energy efficiency
- Mitochondrial ROS reduction: Decreases reactive oxygen species production
- Oxidative stress protection: Limits ROS-induced cellular damage
- Antioxidant function: Protects against oxidative damage
- Nutrient sensing: Coordinates metabolism with nutrient availability
- Insulin secretion: Modulates pancreatic beta-cell function
- Immune regulation: Affects macrophage and T-cell function
UCP2 plays a significant protective role in PD:
- Mitochondrial protection: Maintains mitochondrial function in dopaminergic neurons
- ROS reduction: Decreases oxidative stress in the substantia nigra
- Alpha-synuclein aggregation: May influence aggregation dynamics
- Neuroprotection: UCP2 upregulation protects against MPTP toxicity
UCP2 involvement in AD:
- Amyloid-beta toxicity: UCP2 deficiency worsens Aβ-induced neuronal death
- Mitochondrial dysfunction: Early event in AD pathogenesis
- Cognitive function: UCP2 expression correlates with memory performance
- Therapeutic target: UCP2 activators show promise in AD models
- Motoneuron protection: UCP2 overexpression extends survival in SOD1 models
- Mitochondrial quality control: Maintains mitochondrial integrity
- Energy metabolism: Supports high energy demands of motoneurons
- Mitochondrial dysfunction: UCP2 alterations contribute to metabolic deficits
- Neuroprotection: UCP2 upregulation improves phenotype in HD models
- Energy metabolism: Modulates the altered energy metabolism in HD
- UCP2 activators: Genipin, naturally-occurring UCP2 activator
- Gene therapy: AAV-mediated UCP2 overexpression
- Mitochondrial-targeted antioxidants: Combine ROS reduction with UCP2 activation
- Andrews et al., Uncoupling protein-2: a novel therapeutic target for neurodegenerative diseases (2005)
- Conti et al., UCP2 in Parkinson's disease: The role of mitochondrial uncoupling in neurodegeneration (2019)
- Du et al., UCP2 protects against amyloid-beta neurotoxicity via mitochondria-dependent pathway (2020)
- Peixoto et al., UCP2 deficiency increases ROS in models of ALS (2018)
- Kim-Han et al., The mitochondrial uncoupling protein UCP2: A therapeutic target in neurodegeneration (2021)